Julien Limenitakis

@jlimenitakis

Scientist working on microbial communities and antibody repertoires

Bern, Schweiz
Vrijeme pridruživanja: lipanj 2016.

Tweetovi

Blokirali ste korisnika/cu @jlimenitakis

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @jlimenitakis

  1. proslijedio/la je Tweet
    1. velj

    in 2019, I reviewed a total of 22 articles in for my immunology . Most of them deal with , , , T cells, immunology. Here is the brief summary for each of them

    Prikaži ovu nit
    Poništi
  2. proslijedio/la je Tweet
    2. velj

    Tracking microbial evolution in the human gut using Hi-C reveals extensive horizontal gene transfer, persistence and adaptation

    Poništi
  3. proslijedio/la je Tweet
    31. sij

    1/14 Why does E. coli clear from the blood faster than S. aureus? I've heard this repeatedly but never fully understood the difference. One answer helps explain why cirrhosis is a risk factor for infection and introduced me to a Trojan horse of the immune system. Read on!

    Prikaži ovu nit
    Poništi
  4. proslijedio/la je Tweet
    27. sij

    Tamara O'Connor & cols: Combinatorial selection in mutiple environmental amoebal hosts drives the evolution of the human pathogen Legionella pneumophila

    Poništi
  5. proslijedio/la je Tweet
    30. sij

    Our latest work unraveling a polarization of metabolic strategies across the earth microbiome is now out on bioRxiv :)

    Poništi
  6. proslijedio/la je Tweet
    29. sij

    RStudio announces today that we are a Certified B-Corp! As a Public Benefit Corp, our long-term mission of creating free & open-source software for data science & scientific research is now part of our corporate charter. Read more at

    RStudio, a Certified B Corporation
    Poništi
  7. proslijedio/la je Tweet
    28. sij

    A "lay" summary of our recent Bayesian phylogenetic hidden Markov model for B cell receptor (i.e. antibody) sequences: . Immunological take-home: if you are doing expensive experiments based on computational reconstructions, don't rely on point estimates.

    Prikaži ovu nit
    Poništi
  8. proslijedio/la je Tweet
    29. sij

    Our preprint is now on biorxiv: Polymorphisms in immunoglobulin heavy chain variable genes and their upstream regions

    Poništi
  9. proslijedio/la je Tweet
    28. sij
    Odgovor korisnicima

    Absolutely. This caught my attention right away: "A meta-analysis of non-TCGA transcriptomic data from ~18,000 human tumours found that the relative abundance of intratumoural plasma cells is one of the most significant positive prognostic factors"

    Poništi
  10. proslijedio/la je Tweet
    28. sij

    There's a lot of scared discourse around the new coronavirus, and specifically around a concept called R0. I wrote this piece about what that number is, what it means, and--crucially--what it does NOT mean.

    Poništi
  11. proslijedio/la je Tweet
    27. sij

    Wuhan is to biotech what Shenzhen is to electronics. White label manufacturers there make many critical reagents sold by major lab supply vendors. If the lockdown continues, research worldwide may be affected.

    Poništi
  12. proslijedio/la je Tweet
    28. sij

    Antibiotic resistance: turning evolutionary principles into clinical reality | FEMS Microbiology Reviews | Oxford Academic

    Poništi
  13. proslijedio/la je Tweet
    28. sij

    Microbial competition reduces interaction distances to the low µm-range bioRxiv from w/

    Poništi
  14. proslijedio/la je Tweet
    27. sij

    B cells, plasma cells and antibody repertoires in the tumour microenvironment | | Dmitriy Chudakov | Review

    Poništi
  15. proslijedio/la je Tweet

    Comparison of visualisation tools for single-cell RNAseq data | bioRxiv

    Poništi
  16. proslijedio/la je Tweet
    25. sij

    Comparisons of the antibody repertoires of a humanized rodent and humans by high throughput sequencing | Scientific Reports

    Poništi
  17. proslijedio/la je Tweet
    24. sij

    Amazing resource of >10k echocardiogram videos! Lets start training models!

    Poništi
  18. proslijedio/la je Tweet
    24. sij

    [1/10] 3 yrs ago, I was 1 mo away from returning to med school when I saw a peculiar trend in sequencing data. I hesitated at first, then canceled my classes, applied to PhD, and embarked on an incredible journey. I am happy to share the fruits of my labor:

    Prikaži ovu nit
    Poništi
  19. proslijedio/la je Tweet
    23. sij

    New work from our team - "Human immune system variation during one year". Healthy, middle-aged individuals

    Prikaži ovu nit
    Poništi
  20. proslijedio/la je Tweet
    22. sij

    This preprint story itself is a marvel of rigor and resilience of "reusability". Happy to see on ArXiv!

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·